Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Greatbatch goes shopping and snaps up Enpath Medical for $102m

This article was originally published in Clinica

Executive Summary

In a move to expand its offerings to the cardiac rhythm management (CRM) and neurostimulation market, medical device component manufacturer Greatbatch is to acquire Enpath Medical, a company focused on percutaneous delivery systems and stimulation leads technologies. Clarence, New York-based Greatbatch has offered to pay $14.38 for each Enpath share, representing a 29% premium on Enpath's closing price of $11.13 on the last trading day before the announcement was made this Monday (April 30).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel